877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Kappa agonists, Opioid receptor ligands, Antiarrhythmic agents

Categories

Analgesics (5)
Drugs acting on the cardiovascular system (5)
Drugs acting on the nervous system (5)
Euphoriants (5)
Monoamine reuptake inhibitors (5)
Mu-opioid agonists (5)
Opioids (5)
Psychoactive drugs (5)
Synthetic opioids (5)
Antianginals (4)
Antidepressants (4)
Antihypertensive agents (4)
Calcium channel blockers (4)
Delta-opioid agonists (4)
Dissociative drugs (4)
Drugs acting on the respiratory system (4)
GABA receptor antagonists (4)
GABA receptor ligands (4)
Nociceptin receptor agonists (4)
Psychopharmacology (4)
Respiratory system drug (4)
Serotonin-norepinephrine reuptake inhibitors (4)
Pharmaceuticals (2)
Anesthetics (1)
Convulsants (1)
Cyclic compounds (1)
Local anesthetics (1)
Neurotoxins (1)
Piperidines (1)
Serotonin-norepinephrine-dopamine reuptake inhibitors (1)
Six-membered rings (1)
Sodium channel blockers (1)

Suppliers

Sigma Aldrich (2)

meperidine (57-42-1)  
Demerol  ·  Dolin  ·  Pethidine
Pethidine, also known as meperidine and sold under the brand name Demerol among others, is a synthetic opioid pain medication of the phenylpiperidine class. Synthesized in 1939 as a potential anticholinergic agent by the German chemist Otto Eisleb, its analgesic properties were first recognized by Otto Schaumann while working for IG Farben, Germany. Pethidine is the prototype of a large family of analgesics including the pethidine 4-phenylpiperidines (piminodine, anileridine and others), the prodines (alphaprodine, MPPP, etc.), bemidones (ketobemidone, etc.) and others more distant, including diphenoxylate and analogues.
levorphanol (77-07-6, 297-90-5)  
Levorphanol Tartrate  ·  Levorphan  ·  LevoDromoran
Levorphanol (INN; brand name Levo-Dromoran) is an opioid medication used to treat moderate to severe pain. It is one of four enantiomers of the compound racemorphan, and was first described in Germany in 1948 as an orally active, morphine-like analgesic. The drug has been in clinical use in the United States since 1953.
DEXTRORPHAN (297-90-5, 125-73-5)  
(+-)-17-Methylmorphinan-3-ol
Dextrorphan (DXO) is a psychoactive drug of the morphinan class which acts as an antitussive or cough suppressant and dissociative hallucinogen. It is the dextrorotatory-stereoisomer of racemorphan, the levo-half being levorphanol. Dextrorphan is produced by O-demethylation of dextromethorphan by CYP2D6.
Racemorphan (297-90-5)  
Racemorphan, or morphanol, is the racemic mixture of the two stereoisomers of 17-methylmorphinan-3-ol, each with differing pharmacology and effects: Dextrorphan - an antitussive and dissociative hallucinogen (NMDA receptor antagonist) Levorphanol - an opioid analgesic Racemorphan itself is under international control per the Single Convention on Narcotic Drugs 1961 and is therefore listed as a Schedule II Narcotic controlled substance in the US Controlled Substances Act 1970; it has an ACSCN of 9733 and in 2014 it had an aggregate annual manufacturing quota of zero. The salts in use are hydrobromide (free base conversion ratio 0.741), hydrochloride (0.876), and tartrate (0.632).
125-73-5 (125-73-5)  
Dextrorphan (DXO) is a psychoactive drug of the morphinan class which acts as an antitussive or cough suppressant and dissociative hallucinogen. It is the dextrorotatory-stereoisomer of racemorphan, the levo-half being levorphanol. Dextrorphan is produced by O-demethylation of dextromethorphan by CYP2D6.
Related searches
Kappa agonists
Opioid receptor ligands
Antiarrhythmic agents